174 related articles for article (PubMed ID: 34189602)
1. Cardiopulmonary exercise testing and prognosis in patients with systemic sclerosis without baseline pulmonary hypertension: a prospective cohort study.
Bournia VK; Kallianos A; Panopoulos S; Gialafos E; Velentza L; Vlachoyiannopoulos PG; Sfikakis PP; Trakada G
Rheumatol Int; 2022 Feb; 42(2):303-309. PubMed ID: 34189602
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of cardiopulmonary exercise test in the prediction of disease progression in systemic sclerosis.
Hemelein RA; Lajkó I; Baráth K; Varga J; Ágoston G; Hulló D; Bocskai M; Dobi D; Rózsavölgyi Z; Milassin Á; Varga A; Somfay A; Kovács L
Clin Exp Rheumatol; 2021; 39 Suppl 131(4):94-102. PubMed ID: 33769261
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of cardiopulmonary exercise testing in patients with systemic sclerosis.
Ewert R; Ittermann T; Habedank D; Held M; Lange TJ; Halank M; Winkler J; Gläser S; Olschewski H; Kovacs G
BMC Pulm Med; 2019 Nov; 19(1):230. PubMed ID: 31783745
[TBL] [Abstract][Full Text] [Related]
4. Limited Exercise Capacity in Patients with Systemic Sclerosis: Identifying Contributing Factors with Cardiopulmonary Exercise Testing.
Martis N; Queyrel-Moranne V; Launay D; Neviere R; Fuzibet JG; Marquette CH; Leroy S
J Rheumatol; 2018 Jan; 45(1):95-102. PubMed ID: 29093153
[TBL] [Abstract][Full Text] [Related]
5. Isolated diffusing capacity reduction in systemic sclerosis.
Steen VD; Graham G; Conte C; Owens G; Medsger TA
Arthritis Rheum; 1992 Jul; 35(7):765-70. PubMed ID: 1622414
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors for Mortality and Cardiopulmonary Hospitalization in Systemic Sclerosis Patients At Risk for Pulmonary Hypertension, in the PHAROS Registry.
Hsu VM; Chung L; Hummers LK; Shah A; Simms R; Bolster M; Hant FN; Silver RM; Fischer A; Hinchcliff ME; Varga J; Goldberg AZ; Derk CT; Schiopu E; Khanna D; Shapiro LS; Domsic RT; Medsger T; Mayes MD; Furst D; Csuka ME; Molitor JA; Saketkoo LA; Salazar CR; Steen VD
J Rheumatol; 2019 Feb; 46(2):176-183. PubMed ID: 30275260
[TBL] [Abstract][Full Text] [Related]
7. Cardiopulmonary exercise testing for detecting pulmonary arterial hypertension in systemic sclerosis.
Dumitrescu D; Nagel C; Kovacs G; Bollmann T; Halank M; Winkler J; Hellmich M; Grünig E; Olschewski H; Ewert R; Rosenkranz S
Heart; 2017 May; 103(10):774-782. PubMed ID: 28062514
[TBL] [Abstract][Full Text] [Related]
8. Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population.
Hachulla E; Clerson P; Airò P; Cuomo G; Allanore Y; Caramaschi P; Rosato E; Carreira PE; Riccieri V; Sarraco M; Denton CP; Riemekasten G; Pozzi MR; Zeni S; Mihai CM; Ullman S; Distler O; Rednic S; Smith V; Walker UA; Matucci-Cerinic M; Müller-Ladner U; Launay D;
Rheumatology (Oxford); 2015 Jul; 54(7):1262-9. PubMed ID: 25596413
[TBL] [Abstract][Full Text] [Related]
9. Reduced ventilatory efficiency during exercise predicts major vascular complications and mortality for interstitial lung disease in systemic sclerosis.
Rosato E; Leodori G; Gigante A; Di Paolo M; Paone G; Palange P
Clin Exp Rheumatol; 2020; 38 Suppl 125(3):85-91. PubMed ID: 32865173
[TBL] [Abstract][Full Text] [Related]
10. Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis.
Goh NS; Hoyles RK; Denton CP; Hansell DM; Renzoni EA; Maher TM; Nicholson AG; Wells AU
Arthritis Rheumatol; 2017 Aug; 69(8):1670-1678. PubMed ID: 28426895
[TBL] [Abstract][Full Text] [Related]
11. Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity.
Michelfelder M; Becker M; Riedlinger A; Siegert E; Drömann D; Yu X; Petersen F; Riemekasten G
Clin Rheumatol; 2017 Feb; 36(2):381-390. PubMed ID: 28028682
[TBL] [Abstract][Full Text] [Related]
12. Mortality and hospitalization outcomes of interstitial lung disease and pulmonary hypertension in the Singapore systemic sclerosis cohort.
Noviani M; Saffari SE; Tan JL; Yip JWL; Teng GG; Law WG; Chan GYL; Santosa A; Lim AYN; Hong C; Ng SA; Tay ELW; Ruan W; Yap J; Low AHL
Semin Arthritis Rheum; 2020 Jun; 50(3):473-479. PubMed ID: 31810742
[TBL] [Abstract][Full Text] [Related]
13. Sex-specific cardiopulmonary exercise testing indices to estimate the severity of inoperable chronic thromboembolic pulmonary hypertension.
Chen TX; Pudasaini B; Guo J; Gong SG; Jiang R; Wang L; Zhao QH; Wu WH; Yuan P; Liu JM
Int J Chron Obstruct Pulmon Dis; 2018; 13():385-397. PubMed ID: 29416329
[TBL] [Abstract][Full Text] [Related]
14. Exercise Pulmonary Resistances Predict Long-Term Survival in Systemic Sclerosis.
Zeder K; Avian A; Bachmaier G; Douschan P; Foris V; Sassmann T; Moazedi-Fuerst FC; Graninger WB; Hafner F; Brodmann M; Salmhofer W; Olschewski H; Kovacs G
Chest; 2021 Feb; 159(2):781-790. PubMed ID: 32931822
[TBL] [Abstract][Full Text] [Related]
15. Determinants of exercise-induced pulmonary arterial hypertension in systemic sclerosis.
Voilliot D; Magne J; Dulgheru R; Kou S; Henri C; Laaraibi S; Sprynger M; Andre B; Pierard LA; Lancellotti P
Int J Cardiol; 2014 May; 173(3):373-9. PubMed ID: 24684997
[TBL] [Abstract][Full Text] [Related]
16. Functional and Exercise Limitations After a First Episode of Pulmonary Embolism: Results of the ELOPE Prospective Cohort Study.
Kahn SR; Hirsch AM; Akaberi A; Hernandez P; Anderson DR; Wells PS; Rodger MA; Solymoss S; Kovacs MJ; Rudski L; Shimony A; Dennie C; Rush C; Geerts WH; Aaron SD; Granton JT
Chest; 2017 May; 151(5):1058-1068. PubMed ID: 27932051
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease.
Launay D; Humbert M; Berezne A; Cottin V; Allanore Y; Couderc LJ; Bletry O; Yaici A; Hatron PY; Mouthon L; Le Pavec J; Clerson P; Hachulla E
Chest; 2011 Oct; 140(4):1016-1024. PubMed ID: 21474572
[TBL] [Abstract][Full Text] [Related]
18. Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study.
Hsu VM; Chung L; Hummers LK; Wigley F; Simms R; Bolster M; Silver R; Fischer A; Hinchcliff ME; Varga J; Goldberg AZ; Derk CT; Schiopu E; Khanna D; Shapiro LS; Domsic RT; Medsger T; Mayes MD; Furst D; Csuka ME; Molitor JA; Alkassab F; Steen VD
Semin Arthritis Rheum; 2014 Aug; 44(1):55-62. PubMed ID: 24709277
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and survival of systemic sclerosis patients with pulmonary hypertension and elevated wedge pressure: Observations from the PHAROS cohort.
Lammi MR; Saketkoo LA; Gordon JK; Lauto P; Fagan K; Steen VD;
Respirology; 2017 Oct; 22(7):1386-1392. PubMed ID: 28500695
[TBL] [Abstract][Full Text] [Related]
20. Cardiopulmonary exercise factors predict survival in patients with advanced interstitial lung disease referred for lung transplantation.
Layton AM; Armstrong HF; Kim HP; Meza KS; D'Ovidio F; Arcasoy SM
Respir Med; 2017 May; 126():59-67. PubMed ID: 28427551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
